These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33511662)

  • 1. COVID-19-induced toxic epidermal necrolysis.
    Narang I; Panthagani AP; Lewis M; Chohan B; Ferguson A; Nambi R
    Clin Exp Dermatol; 2021 Jul; 46(5):927-929. PubMed ID: 33511662
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.
    Tanaka A; Isei M; Kikuzawa C; Hinogami H; Nishida K; Gohma I; Ogawa Y
    J Dermatol; 2021 Mar; 48(3):e144-e145. PubMed ID: 33439527
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges in the treatment of a patient with toxic epidermal necrolysis associated with COVID-19: A case report.
    Emadi SN; Hamzelou S; Saffarian Z; Shakoei S
    Dermatol Ther; 2021 Jan; 34(1):e14656. PubMed ID: 33301196
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in a patient with psoriatic arthritis.
    Pace J; Adami JZ; Mallia C; Mizzi A
    Adv Exp Med Biol; 1999; 455():557-60. PubMed ID: 10599399
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 6. Asboe-Hansen sign in toxic epidermal necrolysis.
    Dowling JR; Anderson KL; Huang WW
    Cutis; 2019 Apr; 103(4):E6-E8. PubMed ID: 31116821
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 infection increases the development of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort analysis.
    Curtis KK; Dillan MM; Sharma TR; Piktel J
    J Am Acad Dermatol; 2024 Jun; 90(6):1300-1302. PubMed ID: 38423469
    [No Abstract]   [Full Text] [Related]  

  • 8. Corticosteroids in Stevens-Johnson Syndrome/toxic epidermal necrolysis: current evidence and implications for future research.
    Law EH; Leung M
    Ann Pharmacother; 2015 Mar; 49(3):335-42. PubMed ID: 25406459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome following concurrent phenytoin and holocranial radiotherapy.
    Goyal S; Biswas A; Puri T; Mohanti BK
    Acta Oncol; 2010; 49(2):259-60. PubMed ID: 19888894
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulvestrant-induced toxic epidermal necrolysis.
    Morales-Conde M; López-Ibáñez N; Calvete-Candenas J; Mendonça FMI
    An Bras Dermatol; 2019; 94(2):218-220. PubMed ID: 31090829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib.
    Nühnen VP; Schön MP; Mössner R
    J Dtsch Dermatol Ges; 2018 Feb; 16(2):199-201. PubMed ID: 29328518
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: 'Killing 2 birds with one stone'.
    Saha M; D'Cruz A; Paul N; Healy R; Collins D; Charles DA; Sahu S; Fonia A
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e97-e98. PubMed ID: 32805059
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].
    Fernández FA; Pintor E; Quesada R; Garcés FJ
    Actas Dermosifiliogr; 2007 Sep; 98(7):483-5. PubMed ID: 17669303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination.
    Kherlopian A; Zhao C; Ge L; Forward E; Fischer G
    Australas J Dermatol; 2022 Feb; 63(1):e93-e95. PubMed ID: 34751429
    [No Abstract]   [Full Text] [Related]  

  • 15. Stevens-Johnson syndrome.
    Araujo OE; Flowers FP
    J Emerg Med; 1984; 2(2):129-35. PubMed ID: 6396327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam.
    van der Meer JB; Schuttelaar ML; Toth GG; Kardaun SH; Beerthuizen G; de Jong MC; Jonkman MF; Nieuwenhuis P
    Clin Exp Dermatol; 2001 Nov; 26(8):654-6. PubMed ID: 11722448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D; Zachariae C; Thomsen SF
    Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome: getting ready for the year 2000 and beyond.
    Patterson R; Tripathi A
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):339-40. PubMed ID: 10582711
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.